Cross-Reactivity among Beta-Lactams

Antonino Romano1,2, Francesco Gaeta3, Maria Francisca Arribas Poves4

  • 1Allergy Unit, Complesso Integrato Columbus, Via G. Moscati, 31, 00168, Rome, Italy. aromano.allergy@gmail.com.

Insights

Beta-lactam antibiotic hypersensitivity reactions are common. Cross-reactivity between penicillins and cephalosporins is often linked to similar side chains, while reactions to carbapenems and aztreonam are rare in penicillin-allergic patients.

Area of Science:

  • Immunology
  • Pharmacology
  • Allergy

Background:

  • Beta-lactam (BL) antibiotics, including penicillins and cephalosporins, are widely used but frequently cause drug hypersensitivity reactions.
  • Minor BL classes include monobactams, carbapenems, oxacephems, and beta-lactamase inhibitors.

Purpose of the Study:

  • To review prospective studies evaluating cross-reactivity among different beta-lactam antibiotic classes in patients with confirmed hypersensitivity to a specific BL.
  • To elucidate the role of structural similarities, particularly side chains, in mediating cross-reactivity.

Main Methods:

  • Analysis of prospective studies involving allergy testing with alternative BLs in subjects with documented hypersensitivity to a particular BL class.
  • Administration of alternative BLs to patients with negative allergy test results.

Main Results:

  • Cross-reactivity among BLs, especially between penicillins and cephalosporins, is primarily associated with structural similarities in their side chains.
  • In penicillin-allergic individuals, cross-reactivity with cephalosporins sharing identical side chains can exceed 30%.
  • Cross-reactivity between penicillins and carbapenems or aztreonam is less than 1% in penicillin-allergic subjects.

Conclusions:

  • Hypersensitivity cross-reactivity among beta-lactam antibiotics is largely driven by side-chain determinants.
  • While rare, cross-reactivity involving the core beta-lactam ring or coexisting sensitivities due to prior exposures can occur.

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

Overview
33.8K
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
22
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.4K
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
25
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.9K
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
60